AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 1 filers reported holding AZURRX BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,398,000 | +66.4% | 2,924,088 | +171.9% | 0.00% | – |
Q1 2021 | $1,441,000 | +116.7% | 1,075,484 | +56.8% | 0.00% | – |
Q4 2020 | $665,000 | +27.6% | 685,922 | -6.3% | 0.00% | – |
Q3 2020 | $521,000 | -16.4% | 732,132 | +6.5% | 0.00% | – |
Q2 2020 | $623,000 | +53.8% | 687,164 | -1.6% | 0.00% | – |
Q1 2020 | $405,000 | -44.2% | 698,538 | 0.0% | 0.00% | – |
Q4 2019 | $726,000 | +73.3% | 698,538 | 0.0% | 0.00% | – |
Q3 2019 | $419,000 | -5.4% | 698,538 | +168.4% | 0.00% | – |
Q2 2019 | $443,000 | +150.3% | 260,306 | +255.0% | 0.00% | – |
Q1 2019 | $177,000 | +98.9% | 73,321 | 0.0% | 0.00% | – |
Q4 2018 | $89,000 | -91.6% | 73,321 | -82.3% | 0.00% | – |
Q3 2018 | $1,063,000 | -18.2% | 413,439 | +2.1% | 0.00% | – |
Q2 2018 | $1,300,000 | +264.1% | 404,950 | +256.5% | 0.00% | – |
Q1 2018 | $357,000 | +8.2% | 113,584 | +27.2% | 0.00% | – |
Q4 2017 | $330,000 | +0.6% | 89,278 | +8.7% | 0.00% | – |
Q3 2017 | $328,000 | – | 82,133 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PARSONS CAPITAL MANAGEMENT INC/RI | 434,783 | $1,117,000 | 0.12% |
J. Goldman & Co LP | 425,358 | $1,093,000 | 0.08% |
683 Capital Management, LLC | 400,000 | $1,028,000 | 0.07% |
ARDSLEY ADVISORY PARTNERS LP | 150,000 | $386,000 | 0.05% |
GILDER GAGNON HOWE & CO LLC | 556,537 | $1,430,000 | 0.02% |
TIEDEMANN ADVISORS, LLC | 60,000 | $154,000 | 0.01% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 131,456 | $338,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 22,780 | $59,000 | 0.01% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $1,285,000 | 0.00% |
Rockefeller Capital Management L.P. | 16,971 | $44,000 | 0.00% |